Tomohito Gohda Selected Research

Type I Tumor Necrosis Factor Receptors

1/2022	Progranulin and Its Receptor Predict Kidney Function Decline in Patients With Type 2 Diabetes.
1/2021	Association between circulating tumor necrosis factor receptors and oral bacterium in patients receiving hemodialysis: a cross-sectional study.
10/2018	Association between circulating tumor necrosis factor-related biomarkers and estimated glomerular filtration rate in type 2 diabetes.
12/2017	Effect of tonsillectomy with steroid pulse therapy on circulating tumor necrosis factor receptors 1 and 2 in IgA nephropathy.
1/2017	Circulating TNF Receptors 1 and 2 Predict Mortality in Patients with End-stage Renal Disease Undergoing Dialysis.
1/2015	Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy.
1/2013	Risk of ESRD and all cause mortality in type 2 diabetes according to circulating levels of FGF-23 and TNFR1.
3/2012	Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes.
3/2012	Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomohito Gohda Research Topics

Disease

29	Diabetic Nephropathies (Diabetic Nephropathy) 12/2020 - 07/2004
14	Albuminuria 01/2022 - 12/2003
13	Type 2 Diabetes Mellitus (MODY) 01/2022 - 05/2008
11	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 03/2012
11	Inflammation (Inflammations) 01/2022 - 06/2005
11	Proteinuria 11/2021 - 01/2003
6	Chronic Renal Insufficiency 11/2021 - 04/2018
5	Hyperglycemia 12/2020 - 08/2005
5	Fibrosis (Cirrhosis) 01/2020 - 03/2006
5	Body Weight (Weight, Body) 01/2012 - 08/2005
5	Glucose Intolerance 07/2009 - 11/2004
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2017
4	Hypertension (High Blood Pressure) 01/2021 - 08/2005
4	IGA Glomerulonephritis (IGA Nephropathy) 12/2017 - 01/2003
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2014 - 03/2012
4	Insulin Resistance 01/2010 - 01/2004
3	Hematuria 12/2017 - 01/2003
3	Schizophrenia (Dementia Praecox) 01/2017 - 04/2015
3	Dyslipidemias (Dyslipidemia) 05/2015 - 08/2005
3	Diabetes Complications 03/2012 - 02/2009
2	Periodontal Diseases (Periodontal Disease) 01/2022 - 12/2020
2	Periodontitis 01/2022 - 01/2021
2	COVID-19 11/2021 - 05/2021
2	Atherosclerosis 01/2013 - 01/2008
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2010 - 07/2009
1	Tooth Loss 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 05/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2021
1	Critical Illness (Critically Ill) 05/2021
1	Cerebral Infarction 05/2021
1	Cytokine Release Syndrome 05/2021
1	Hyperuricemia 01/2021
1	Dental Caries (Decay, Dental) 12/2020
1	Dental Plaque 12/2020
1	Microvascular Rarefaction 10/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2020
1	Frailty 10/2020
1	Sarcopenia 10/2020
1	Acute Kidney Injury (Acute Renal Failure) 03/2020

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2003
14	AlbuminsIBA 01/2021 - 11/2004
11	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2021 - 03/2012
9	Type I Tumor Necrosis Factor ReceptorsIBA 01/2022 - 03/2012
8	CreatinineIBA 01/2021 - 02/2006
8	Type II Tumor Necrosis Factor ReceptorsIBA 01/2021 - 03/2012
7	Advanced Glycation End ProductsIBA 10/2020 - 08/2005
7	Proteins (Proteins, Gene)FDA Link 04/2018 - 01/2003
6	Triglycerides (Triacylglycerol)IBA 01/2010 - 08/2005
5	Blood Glucose (Blood Sugar)IBA 07/2009 - 08/2005
4	CytokinesIBA 05/2021 - 01/2011
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 01/2017
4	C-Reactive ProteinIBA 01/2021 - 01/2008
3	Uric Acid (Urate)IBA 01/2021 - 01/2010
3	pentosidineIBA 01/2017 - 08/2008
3	Angiotensin IIIBA 01/2013 - 12/2004
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2012 - 02/2007
3	PyridoxamineIBA 07/2009 - 02/2007
3	Transforming Growth Factor beta (TGF-beta)IBA 12/2006 - 06/2005
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 12/2006
2	ProgranulinsIBA 01/2022 - 10/2018
2	ImmunosorbentsIBA 01/2022 - 04/2015
2	EnzymesIBA 01/2022 - 04/2015
2	Interleukin-6 (Interleukin 6)IBA 11/2021 - 05/2021
2	Messenger RNA (mRNA)IBA 01/2021 - 07/2004
2	SteroidsIBA 12/2017 - 12/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2015 - 06/2011
2	Receptor for Advanced Glycation End ProductsIBA 04/2015 - 02/2006
2	Immunoglobulin A (IgA)IBA 07/2012 - 01/2003
2	mindinIBA 07/2011 - 01/2011
2	NADPH Oxidases (NAD(P)H oxidase)IBA 06/2011 - 12/2004
2	Fibronectins (Fibronectin)IBA 06/2011 - 06/2005
2	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2011 - 06/2005
2	Hemoglobins (Hemoglobin)IBA 01/2010 - 05/2008
2	Glucose (Dextrose)FDA LinkGeneric 07/2009 - 05/2008
2	CholesterolIBA 05/2008 - 02/2007
2	Insulin (Novolin)FDA Link 01/2008 - 02/2007
2	Eicosapentaenoic AcidIBA 12/2006 - 03/2006
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2006 - 02/2006
2	PPAR gammaIBA 06/2005 - 01/2004
1	Oxygen (Dioxygen)IBA 11/2021
1	Polymyxin B (Aerosporin)FDA LinkGeneric 05/2021
1	Xanthine OxidaseIBA 01/2021
1	purineIBA 01/2021
1	Febuxostat FDA Link 01/2021
1	Sodium-Glucose Transport ProteinsIBA 12/2020
1	6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA 12/2020
1	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2020
1	Nucleotide AptamersIBA 10/2020
1	Aspartic Acid (Aspartate)FDA Link 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Extracellular Matrix ProteinsIBA 01/2020

Therapy/Procedure

9	Renal Dialysis (Hemodialysis) 01/2022 - 06/2002
5	Therapeutics 12/2017 - 01/2011
2	Nephrectomy 10/2020 - 01/2008
2	Tonsillectomy 12/2017 - 12/2016
1	Hemoperfusion 05/2021
1	Hemodiafiltration 05/2021
1	Peritoneal Dialysis 05/2021
1	Plasma Exchange 05/2021
1	Oral Hygiene (Dental Hygiene) 12/2020